BAM-15

FDA APPROVAL PENDING

Moderate Research

Weight

Metabolic

Weight

BAM-15

Metabolic

Amino acid sequence

5

Amino acids

326.28da

Molecular weight

Peptide

Type

BAM-15 is a synthetic mitochondrial uncoupler that has emerged as a promising research compound for obesity and metabolic disorders. Unlike traditional uncouplers like DNP which have serious toxicity concerns, BAM-15 demonstrates a superior safety profile while effectively increasing energy expenditure and fat oxidation. Research in mice shows BAM-15 reduces body fat without affecting food intake, lean mass, or body temperature. It is approximately 7-fold more potent than DNP and does not induce the dangerous hyperthermia associated with older uncouplers. Note: BAM-15 is a small molecule compound, not a peptide, but is commonly sold alongside peptide products.

Top researched benefits

Overview of BAM-15

BAM-15 targets the inner mitochondrial membrane, enhancing proton permeability and dissipating the proton gradient. This uncouples electron transport from ATP synthesis, forcing mitochondria to increase respiration and burn more substrates (particularly fat) to maintain energy production. BAM-15 activates AMP-activated protein kinase (AMPK) in response to ATP depletion, promoting glucose uptake and fatty acid oxidation. It also activates PGC-1α (peroxisome proliferator-activated receptor gamma coactivator 1-alpha), enhancing mitochondrial biogenesis. Unlike DNP or FCCP, BAM-15 does not depolarize plasma membranes or induce apoptosis at effective concentrations, explaining its improved safety profile.

Metabolic Research

  • Reduces body fat by increasing energy expenditure and fat oxidation without reducing food intake.
  • Research shows reversal of diet-induced insulin resistance in mouse models.
  • Addresses multiple components of metabolic syndrome through enhanced energy expenditure.

Combination Therapy Research

  • 2024 research shows combining BAM-15 with semaglutide produces stronger metabolic benefits than either alone by countering metabolic adaptation.
  • May help overcome weight loss plateaus by preventing metabolic adaptation/efficiency.

Other Research Areas

  • Research shows decreased liver triglycerides in treated animals.
  • Improved glucose tolerance observed in research models.

Storage

Room temperature, protect from light and moisture

Frequency

Once or twice daily with meals

Typical Dose

25-50 mg oral

Cycle Duration

4-8 weeks based on research protocols

Chemical Makeup

Key benefits

Increases fat oxidation without affecting food intake

Reduces body fat mass in research models

7-fold more potent than DNP with better safety

Does not cause dangerous hyperthermia

No effect on lean body mass

Improves insulin sensitivity

Orally bioavailable

Activates AMPK and PGC-1α pathways

Synergistic with GLP-1 agonists (semaglutide)

Community interest

This peptide is still gaining traction in the community.

Mitochondrial Uncoupler | Metabolic Enhancer

This overview is informational and based on aggregated descriptions from studies and user reports.

Was it helpful?Yes

BAM-15 Molecular Information

View the scientifc details of BAM-15.

5

Amino Acids

BAM-15

Cys

Cys

Position 1

His

His

Position 2

Phe

Phe

Position 3

Asn

Asn

Position 4

Pyl

Pyl

Position 5

Amino acid sequence
CysteinePosition 1
HistidinePosition 2
PhenylalaninePosition 3
AsparaginePosition 4
PyrrolysinePosition 5

Molecular Weight

326.28Da

Chain Length

5Amino Acids

Type

Peptide

BAM-15 Protocols

BAM-15 is orally bioavailable and is typically administered as an oral supplement in tablet or capsule form. Research in mice used dietary supplementation (0.1% of diet) or oral gavage dosing. Human dosing protocols are still being established through ongoing research. The compound has a relatively short half-life, which researchers are working to improve through structural modifications.

GoalDosageFrequencyRoute
Metabolic enhancement251 week rangeOral
Research protocol (mouse equivalent)101 week rangeOral gavage

BAM-15 Cycle

The BAM-15 Cycle section explains how long a typical cycle lasts and what to expect during each phase. Over time, your body can become less responsive with continuous use.

Taking breaks between cycles may help maintain effectiveness and support better overall results.

Week 0-0
Increased oxygen consumption and metabolic rate
Day 1-7
Shift toward fat oxidation (lower respiratory exchange ratio)
Week 2-4
Measurable fat mass reduction in research
Week 4-8
Improved insulin sensitivity and glucose tolerance

Dosing tools

BAM-15 Peptide Dosage Calculator

Calculate peptide doses with our visual syringe guide.

0.3mL / 30 units

5 units

0.050 mL

1 mL

2 mL

3 mL

5 mL

Custom

Conversion: 1,000 mcg = 1 mg

Injection Results

Based on your vial and dilution inputs.

Safe concentration range

BAM-15

SINGLE COMPOUND

Volume per injection

0.05

mL

Concentration

10.00

mg/mL

Doses per vial

20

doses

Total injections per vial

20 injections

How it works

Based on a 10 mg BAM-15 vial diluted with 1 mL of bacteriostatic water, each 500 mcg injection equals 0.05 mL.

Research Purposes Only

These calculators are provided for educational and research purposes only. Always verify calculations and consult with qualified professionals. The information provided is not medical advice. Peptides should only be used in accordance with applicable laws and regulations.

Reference Guide

Dosing Cycle

Peptide
BAM-15
Dosing
25-50 mg oral
Dosing Frequency
Once or twice daily with meals
Cycle Duration
4-8 weeks based on research protocols
Storage
Room temperature, protect from light and moisture

Note: Triple agonist; microdose for fewer side effects

Reconstitution Tips

  • Use bacteriostatic water (BAC)contains 0.9% benzyl alcohol for preservation
  • Inject water slowlyaim down the vial wall, not directly onto powder
  • Never shakegently swirl or roll the vial until dissolved
  • Store properlyrefrigerate at 2-8°C after reconstitution
  • Use within 28 daysmost reconstituted peptides remain stable for about 4 weeks
  • Keep sterilealways clean vial tops with alcohol before drawing

Peptide Interactions

Research suggestions of BAM-15 interactions with other common peptides and substances.

Longevity

mot

Metabolic

MOTS-c

COMPATIBLE

Both affect mitochondrial function but through different mechanisms.

COMPATIBLE

Weight

tir

Metabolic

Tirzepatide

SYNERGISTIC

Similar synergy expected as with semaglutide; helps overcome weight loss plateaus.

SYNERGISTIC

Side effects

Contraindications

Hyperthyroidism or thyroid disorders

Heart conditions

Pregnancy or breastfeeding

Use of other mitochondrial uncouplers (DNP, FCCP)

Fever or active infection

Stop signs

Significant hyperthermia/overheating

Excessive sweating

Rapid heart rate

Difficulty breathing

Bad signs

Discolored productNo purity informationUnknown origin
Was it helpful?Yes

Comments

0.0

0 reviews

5

4

3

2

1

No comments yet

Be the first to share your experience. Your review helps others make more informed decisions.

Frequently asked questions

What benefits can peptides offer in research?

Peptides can support cellular repair, immune function, metabolic health, and tissue regeneration. Research suggests they may help with recovery, sleep quality, skin health, and cognitive function, depending on the specific peptide and its mechanism of action.

What are some exciting applications of peptides in modern science?

Current research explores peptides for longevity, muscle recovery, wound healing, metabolic disorders, and neuroprotection. Scientists are also investigating peptide-based drug delivery and targeted therapies that could offer more precise treatment options.

How do peptides influence health and wellness?

Peptides work by binding to receptors on cells and triggering specific biological responses. Depending on the peptide, they may promote growth hormone release, support collagen production, modulate inflammation, or influence neurotransmitter activity—each with different implications for health and wellness.

Where can I find the latest studies on peptide applications?

Peer-reviewed journals such as Nature, Science, and specialized publications like Peptides and the Journal of Peptide Science publish ongoing research. PubMed and Google Scholar are useful for searching studies by peptide name or condition.

Are there any guidelines for using peptides in research?

Research use of peptides typically follows institutional review board (IRB) protocols and regulatory guidelines. Dosage, administration route, and safety monitoring should align with published literature and applicable regulations in your jurisdiction.

What is the difference between peptides and proteins?

Peptides are short chains of amino acids (typically under 50), while proteins are longer chains that fold into complex structures. Peptides are often more stable, easier to synthesize, and can cross cell membranes more readily, making them attractive for therapeutic applications.

How should peptides be stored?

Most peptides require refrigeration (2–8°C) and protection from light. Reconstituted peptides often have shorter stability and may need to be used within days or weeks. Always follow the manufacturer's or research protocol's storage instructions.

Can peptides be taken orally?

Some peptides are bioavailable orally, but many are broken down by digestive enzymes before reaching the bloodstream. Subcutaneous injection, nasal administration, or other routes are often used in research to improve bioavailability. The optimal route depends on the specific peptide.

BAM-15Research References

BAM-15 is a moderate research compound

4Research references

BAM-15

BAM-15 is a moderate research compound

Mitochondrial uncoupler BAM15 reverses diet-induced obesity and insulin resistance in mice

BAM15 is orally bioavailable, increases nutrient oxidation, decreases body fat mass without altering food intake, lean mass, body temperature, or markers of toxicity.

n.d.

BAM15-mediated mitochondrial uncoupling protects against obesity and improves glycemic control

BAM15 is 7-fold more potent than DNP, does not depolarize plasma membranes, and does not induce apoptosis at effective doses.

n.d.

BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases

Comprehensive review of BAM15 mechanisms including AMPK and PGC-1α activation pathways.

n.d.

Beneficial effects of simultaneously targeting calorie intake and calorie efficiency in diet-induced obese mice

Combining semaglutide and BAM15 produces stronger metabolic benefits than either alone; helps overcome metabolic adaptation.

n.d.